Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Preclinical assessment of an adjunctive treatment approach for cognitive impairment associated with schizophrenia using the alpha7 nicotinic acetylcholine receptor agonist WYE-103914\/SEN34625 - Marquis_2011_Psychopharmacology.(Berl)_218_635 |
| Author(s) : Marquis KL , Comery TA , Jow F , Navarra RL , Grauer SM , Pulicicchio C , Kelley C , Brennan JA , Roncarati R , Scali C , Haydar S , Ghiron C , Terstappen GC , Dunlop J |
| Ref : Psychopharmacology (Berl) , 218 :635 , 2011 |
| Abstract : Marquis_2011_Psychopharmacology.(Berl)_218_635 |
| ESTHER : Marquis_2011_Psychopharmacology.(Berl)_218_635 |
| PubMedSearch : Marquis_2011_Psychopharmacology.(Berl)_218_635 |
| PubMedID: 21643676 |
| Title : Poster: In vitro pharmacological characterization and pro-cognitive effects of the selective alpha-7 nicotinic agonist WYE-103914 - |
| Author(s) : Dunlop J , Comery TA , Lock T , Kramer A , Kowal D , Yeola S , Jow F , Aschmies S , Lin Q , Beyer CE , Brennan J , Kelley C , Roncarati R , Scali C , Haydar S , Ghiron C , Marquis KL , Harrison B , Robichaud A , Terstappen GC |
| Ref : Biochemical Pharmacology , 78 :911 , 2009 |
| PubMedID: |
| Title : Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders - Roncarati_2009_J.Pharmacol.Exp.Ther_329_459 |
| Author(s) : Roncarati R , Scali C , Comery TA , Grauer SM , Aschmi S , Bothmann H , Jow B , Kowal D , Gianfriddo M , Kelley C , Zanelli U , Ghiron C , Haydar S , Dunlop J , Terstappen GC |
| Ref : Journal of Pharmacology & Experimental Therapeutics , 329 :459 , 2009 |
| Abstract : Roncarati_2009_J.Pharmacol.Exp.Ther_329_459 |
| ESTHER : Roncarati_2009_J.Pharmacol.Exp.Ther_329_459 |
| PubMedSearch : Roncarati_2009_J.Pharmacol.Exp.Ther_329_459 |
| PubMedID: 19223665 |
| Title : Poster: Characterization of the alpha-7 nicotinic receptor agonist WYE-103914 in models relevant to schizophrenia and interaction with antipsychotics - |
| Author(s) : Marquis KL , Comery TA , Navarra RL , Leiser S , Grauer SM , Pulicicchio C , Kelley C , Roncarati R , Scali C , Haydar S , Ghiron C , Harrison B , Robichaud A , Terstappen GC , Dunlop J |
| Ref : Biochemical Pharmacology , 78 :911 , 2009 |
| PubMedID: |